Indian Association of Colleges of Pharmacy

Kotturpuram, Chennai, Tamilnadu

&

Chelembra, Pulliparamba P.O., Malappuram Dt., Kerala

Devaki Amma Memorial College of Pharmacy

Pharmacy

Practice Module

Advanced Learning Series

Jointly Presents

rd th 23 to 25 September, 2017

Venue

Devaki Amma Memorial

College of Pharmacy

Chelembra, Pulliparamba P.O.,

Malappuram Dt.,

Kerala - 673634

Indian Association of Colleges of Pharmacy

IACP Pharmacy Practice Modules

About the Program

The Indian Association of Colleges of Pharmacy (IACP) registered under Sec 10 of the Tamilnadu Societies

Registration Act 1975 is a national organization whose mission is to serve its member colleges and their

respective faculties, by acting as their advocate at the national level, by providing forums for interaction and

exchange of information among its members, by recognizing outstanding performance among its member

educators and by assisting member colleges and schools in meeting their mission of educating and training

pharmacists and pharmaceutical scientists. The association provides leadership in advancing and enhancing

the quality of Pharmacy education and training in its member colleges. IACP also understands that academic

Pharmacy plays an important role and shares responsibility with the broader profession of Pharmacy.

With the advent of the introduction of the Pharm. D. program in India, Pharmacy educators and students

faced challenges in comprehending this new facet of Pharmacy education and Profession. To strengthen

these initiatives of the council and the educators, the Indian Association of Colleges of Pharmacy (IACP) had

come forward to provide leadership in this area by conducting advanced learning series in understanding

and providing Quality Pharmacy Practice. The IACP has conducted ten such modules and intends to conduct

more such lecture series in the next three years jointly with various stakeholders. The first ten modules have

been conducted successfully and based on the appreciation and request from the Pharm. D. students and

faculty, the modules were quite often repeated in various parts of the country and now the IACP is pleased to

present Pharmacy Practice – Advanced Learning Series – Module 4 (Repeat Module) with a focus on

“Infectious Diseases”

Globally, the pharmacy profession and education are undergoing unprecedented changes and the role of

the pharmacist, as a provider of healthcare services is increasingly recognized, valued and expanded. Many

countries are, however, faced with critical shortages of pharmacy workforce, other healthcare professionals

and workers. The World Health Organization has concluded that in many countries healthcare targets cannot

be realized until capacity is built in the healthcare system.

A primary focus in this regard, is the development of an adequate and appropriate healthcare workforce,

along with the academic and institutional infrastructure to deliver the required competency-based

education and training. Many countries are introducing, expanding or undertaking major reforms of

pharmacy education. Such developments must be accompanied by robust systems to assure the quality of

the educational structures, processes and outcomes; the later primarily being graduates who are competent

and capable of performing safely and effectively in their practice setting and contributing to the delivery of

healthcare.

The Pharmacy Council of India is of firm opinion that introduction of Pharm. D. program with emphasis on

clinical practice, is the need of the hour and is in line with the proclivity in health care standards in this

challenging scenario. The mission of Pharm. D. program is to attune the relation between safe usage of

medication and optimal health benefits. For this mission to be achieved we need caring, competent, ethical

pharmacists who are able to think critically and creatively to identify and resolve the health and medication

related problems by taking responsibilities for managing systems and practices that contribute to the

design, implementation and monitoring of rational pharmacotherapy to effectuate the defined therapeutic

goals with optimal safety and health outcomes.

With an intense intent to strengthen the professional competencies of Indian Pharmacists in healthcare

delivery settings, Pharmacy Council of India (PCI) with the approval of the Ministry of Health and Family

Welfare, Government of India has introduced six year Pharm. D. program in 2008 for entry level pharmacy

students and a three year Post-Baccalaureate Pharm. D. for the working professionals with Bachelor of

Pharmacy degrees through Pharm. D. Regulations, 2008 as notified in the Gazette of India.

About the Organizers

Devaki Amma Memorial Trust was established in 1997 with a vision to emerge as a favored destination of

the finest talents in the country in their pursuit of higher education. The Trust wishes to kindle the quest for

knowledge among students and encourage them to be innovators and thought leaders and to sensitize

students towards social, ecological, and ethical issues. With this view, the Trust made its first foray into the

field of education in 2001, with the establishment of its Teacher Education College offering the B. Ed.

course, and the Trust is now offering D. Ed. (TTC) and M. Ed. Courses. Devaki Amma’s Guruvayurappan

College of Architecture was started in the year 2010 and it currently offers B. Arch. and M. Arch. Courses.

This is the first standalone Architecture College in Kerala and is the first college in Kerala to start M. Arch.

Course and still this is the only self-financing college to offer M. Arch., and PG Courses in Architecture. The

colleges are affiliated to the University of Calicut, Kerala.

Devaki Amma Memorial College of Pharmacy was started functioning in 2003 with B. Pharm. course. It

currently offers D. Pharm., B. Pharm., M. Pharm., Pharm. D. and Ph. D. programs. The college offers M. Pharm.

in the branches like Pharmaceutical Chemistry, Pharmaceutical Analysis, Pharmaceutics and

Pharmacology. the college is an ISO 9001: 2008 certified institution. The current expansion plans includes

the development of a full-fledged R&D Division and Product Development Centers within the Campus. The

College has the best of facilities in Classrooms, Laboratories, Instrument Room and Computer Lab, etc. An

excellent Placement Cell is functioning in the college through which most of the students are placed in

reputed companies and hospitals. The College has also developed an Institution-Industry Interaction Cell

which gets the services of experts from Pharmaceutical Industry for seminars and conferences. The college

campus is located at Chelembra, 18 Km from Calicut Town, 10 Km from Ferok Railway Station and 13 Km

from Calicut International Airport. The Department of Pharmacy Practice was established in tie-up with

PVS Hospital, Calicut, having multi super specialty units and is pioneer in health care sector in Calicut.

Activities and service of the Pharmacy Practice Department includes Drug Information, Patient Counseling,

and ward round participation, ADR monitoring, clinical pharmacology, and poison information centre.

Devaki Amma Memorial College of Pharmacy

About the HostManaging Trustee

Smt. N.C. Parvathy

The program is designed for advanced teaching and learning needs so as to, understand the objectives

underlying certain advanced topics in Pharm. D. program being offered in India. Pharm. D. program was

introduced in India by 2008 to meet the pharmacy practice requirements of the country in providing

quality pharmaceutical care to the patients. Since its introduction, today more than 150 institutions

across the country offer Pharm. D. program. With the increasing number of challenges in learning and

teaching methodologies, this new facet of pharmacy profession in India is also no exception to it. With

the above concept, the IACP and Devaki Amma Memorial College of Pharmacy, Chelembra, Pulliparamba P.O.,

Malappuram Dt., Kerala have joined hands with some of the advanced practitioners and teachers in Pharmacy

practice from other part of the world and have planned to bring this advanced learning Pharmacy Practice

modules for the quality benefit of students and teachers.

Who should attend?

• Dr. Biju C.R. • Dr. R. Nethaji • Dr. A. Suresh • Dr. Shiny George • Mr. Arunlal V. B.• Mr. Byju K. • Dr. Anilasree B. P. • Mrs. Shaimol T. • Mr. Sanjay Sreekumar

President, Pharmacy Council of India, New Delhi &Vice-Chancellor, JSS University, Mysore, Karnataka.

ChairmanProf. Dr. B. Suresh

Organizing Committee

Co-Chairman (Coordinator International)Dr. Krishna Kumar Professor of Biopharmaceuticals & Pharmacokinetics,Howard University, College of Pharmacy,Washington, DC, USA.

Co-Chairman (India)Prof. K. Chinnaswamy President, Indian Association of Colleges of Pharmacy,Chennai.

Secretary Prof. Dr. B. JayakarSecretary, Indian Association of Colleges of Pharmacy, Chennai & Registrar, Vinayaka Mission’s University,Salem.

Program Committee

Dr. B. Jayakar Dr. M.D. Karvekar Dr. V. Ravichandran Dr. T.K. Ravi Dr. T.V. Narayana

Shri. T. Jayapal Reddy Dr. K. Krishnakumar Dr. M. Niranjan Babu

Local Organizing Committee

Program Coordinator

Dr. Siraj Sundaran,

Professor and Head, Department of

Pharmacy Practice, Devaki Amma Memorial

College of Pharmacy, Chelembra, Kerala.

Faculty Coordinators

Managing Trustee Devaki Amma Memorial College of Pharmacy,

Chelembra, Kerala.

Chief PatronSmt. N.C. Parvathy

Chairman

Prof. Dr. G. Babu,

Principal,

Devaki Amma Memorial College

of Pharmacy, Chelembra, Kerala.

Scientific CoordinatorProf. Dr. T. K. Ravi

Vice President, Indian Association of Colleges of Pharmacy, Chennai & Principal, College of Pharmacy,

Sri Ramakrishna Institute of Paramedical Sciences, Coimbatore, Tamilnadu.

ABOUT THE SPEAKERS

Prof. Krishna Kumar, M. Pharm. Ph. D. MPS

Dr. Kumar served

on Presidents Commission on Academic Renewal (HU) as a Commissioner. Dr. Kumar moved to

Howard University from California where he helped to start a new college of Pharmacy at the Western

University of Health Sciences and served as the founding Associate Dean for Graduate Education

and Scholarship. He has also held academic positions in New Zealand, Australia and India. He

serves as a Pharmaceutical consultant to Pharmaceutical Industries in US, India and China on matters

related to API characterization, formulation, pharmacokinetics, bioequivalence and bioavailability

matters. He has also worked in West Africa, China and India as an educational consultant developing

Pharmacy programs and preparing them for accreditation. Dr. Kumar has published widely on

pharmacokinetics and drug delivery. Dr. Kumar has been honored with several Awards including

three Gold Medals from the Banaras Hindu University, India, Laurenson Award, Otago Medical

research Foundation, University of Otago, New Zealand, Special Recognition Award Howard,

University faculty Senate for exemplary service and dedication to the faculty in the categories of

faculty senate leadership, representation and shared governance (2013), Inaugural Distinguished

Service Award for exemplary Service to Pharmacy Education in India, Indian Association of Colleges

of Pharmacy (2014). Dr. Kumar is an active member of several Professional organizations including

AACP. He has served on several Awards committees, nomination committees and SIG committees,

AAPS (awarded PT section champion 2006), Rho Chi, Pharmacy Council New Zealand, Life member

Indian Pharmaceutical Association, Life member, Association of Pharmacy teachers of India, Life

member Indian Association of Colleges of Pharmacy. He earned his Ph.D. from the University of

Otago, New Zealand and completed his post-doctoral fellowship at the Department of Surgery,

University of Melbourne, Australia. Dr. Kumar is a native of Varanasi, India, where he completed his

B. Pharm. and M. Pharm. Degrees in Pharmaceutics/Pharmacokinetics from the Banaras Hindu

University, India. He is married to Dr. Usha Kumar and has a son Dr. Rishi Kumar, a Mayo Clinic

trained Physician.

bioavailability and bioequivalence, and population Pharmacokinetic modeling.

Dr. Krishna Kumar is professor of Biopharmaceutics and Pharmacokinetics at the

College of Pharmacy, Howard University, Washington DC. His research interests

include Characterization of biomarkers and developing epigenetic profile of

African Americans as related to hypertension, cancer and other chronic diseases,

Nano-particles as intelligent tools for Nano-medicine, use of these vehicles for

delivery of anti-cancer drugs and anti HIV drugs, formulation of dosage forms,

Prof. Elizabeth Sherman, Pharm. D.,

rotation students on four-week HIV/AIDS rotations. In the clinic, Dr. Sherman works closely with a

multidisciplinary team of infectious disease clinicians as a clinical pharmacist with expertise in

antiretroviral resistance, drug interactions, and medication adherence. She also serves as Principal

Investigator for the Nova Southeastern University local partner site of the Southeast AIDS Education

and Training Center. Dr. Sherman received her Doctor of Pharmacy from Nova Southeastern

University, completed a pharmacy practice residency with an emphasis in ambulatory care at The

Brooklyn Hospital Center, a specialty residency in HIV/AIDS at the University of California San

Francisco, and is credentialed as an HIV Pharmacist by the American Academy of HIV Medicine.

Dr. Sherman’s clinical research interests focus on improving antiretroviral medication adherence and

advancing patient care by promoting pharmacy services in the primary care setting

Dr. Elizabeth Sherman is an Assistant Professor in the Department of Pharmacy

Practice at Nova Southeastern University in Fort Lauderdale, Florida and an

HIV/AIDS clinical pharmacy specialist providing clinical service for the Memorial

Healthcare System. At the College of Pharmacy, Dr. Sherman lectures on antiviral

agent pharmacotherapy, coordinates the Pharmacotherapy course in infectious

diseases and oncology, and precepts advanced pharmacy practice experience

rdDay 1: Saturday, 23 September, 2017

Medication Therapy Management (MTM) Services were brought into the spotlight of US health care

system, thanks in large part to the Medicare Modernization and Improvement Act of 2003. With this

law, US largest payer of health care services, the United States Government, has recognized the

importance of a set of services that are believed are best provided by the health care system's

expert in medications, the Pharmacist. Medication Therapy Management under the Medicare

prescription drug benefit is certainly a major opportunity for pharmacists to receive payment for

monitoring and improving medication use in patients with complex regimens. Yet, it is only one of

many likely to arise as the health care system continues to see the benefit of appropriately

managed medications. Pharmacists, everywhere have a great opportunity to improve public health,

especially among patients with multiple disease states and complex medication regimens, through

better medication therapy management.

Medication Therapy Management (MTM)

1.Therapeutic Drug Monitoring of Aminoglycosides: Gentamicin, Tobramycin Amikacin and Vancomycin

2.Aminoglycosides

3. Vancomycin

a. Check basic concepts

b. Interface between Physician and Clinical Pharmacist

a. Relationship between CL Gentamicin and CLcr in patients

b. Model selection

c. Bolus model Vs short infusion model

d. Relationship between fraction lost in a day; at steady state and CLcr

e. Therapeutic range

f. How to predict t1/2

g. How to estimate renal clearance

h. Case Studies

a. Indications of use

b. Population parameters

c. Time to sample

d. Therapeutic range

e. Initiate/revise therapy

f. Case studies

IACP - TRAINING MODULE (IV Repeat)

Program

Dr. Miranda Nelson, Pharm. D.,

Dr. Miranda Nelson is the Pediatric Antimicrobial Stewardship Pharmacist and

Pediatric Human Immunodeficiency Virus (HIV) Clinical Pharmacist at St. Louis

Children’s Hospital. Dr. Nelson received her Doctor of Pharmacy degree from

Auburn University in 2005 and subsequently completed a pharmacy practice

residency at St. Louis Children’s Hospital in St. Louis, Missouri. Prior to her current

position Dr. Nelson was a Clinical Associate Professor with the Department of Pharmacy Practice at Southern Illinois University Edwardsville (SIUE) and a Pediatric Infectious

Diseases Clinical Pharmacy Specialist. Dr. Nelson is active at the national level as she previously

served as a board member and is currently President Elect of the Pediatric Pharmacy Advocacy

Group (PPAG).

thDay 2: Sunday, 24 September, 2017

thDay 3: Monday, 25 September, 2017

a. Disease pathophysiology, clinical presentation, and diagnosis

b. Epidemiology of Resistance

c. Treatment Recommendations

d. Monitoring

e. Case studies (in groups)

a. Clinical presentation and disease staging

b. Hepatitis B

i. Prevention

ii. Treatment

iii. Monitoring

c. Hepatitis C

i.Prevention

ii. Treatment

iii. Monitoring

d. Case studies and multiple choice exercises

a. Pathophysiology of antimicrobial resistance

b. Epidemiology of antimicrobial resistance

c. Antimicrobial Stewardship Programs

i.Definition

ii. Strategies to improve antimicrobial use

d. Case example(s)

e. Case studies (in groups)

1.Tuberculosis (Dr. NELSON)

2.Viral Hepatitis (Dr. SHERMAN)

3.Antimicrobial Resistance & Antimicrobial Stewardship (Dr. NELSON)

a. Disease pathophysiology, clinical presentation, and diagnosis

b. Rationale behind current antiretroviral treatment strategies

i.Non-nucleoside reverse transcriptase inhibitors, nucleoside reverse transcriptase

inhibitors, protease inhibitors, entry inhibitors, integrase inhibitors

c. Case studies (in groups)

a. Common side effects and complications of antiretroviral agents and their management

b. Monitoring schedules for HIV therapies

c. Clinically significant drug interactions

d. Case studies (in groups)

a. Disease pathophysiology, clinical presentation, and diagnosis of common opportunistic

infections in patients with AIDS

b. Prophylaxis recommendations

c. Treatment recommendations

d. Monitoring

e. Case studies (in groups)

1.HIV/AIDS: Introduction to HIV and Antiretroviral Therapy (Dr. SHERMAN)

2.HIV/AIDS: Antiretrovirals and HIV Complications (Dr. SHERMAN)

3.Opportunistic Infections (Dr. NELSON)

1.Only registered delegates will be permitted to attend all the above lectures and have

access to various resources in connection with the program.

2.The registered delegates will be provided with the attendance certificate, course

materials and delegate kit bag, besides refreshments during the business hours of

the program.

3.Accommodation will be arranged on request at Hotels/hostels on actual costs. The

interested delegates may contact Prof. Dr. G. Babu, Principal, Devaki Amma Memorial

College of Pharmacy, Chelembra, Malappuram, Kerala, India.

4.The duly filled registration form along with registration fee of Rs. 5500/- (inclusive of

GST) in the form of Demand Draft drawn in favor of IACP payable at Chennai may be

sent to the address given below,

Contact Details

For more details about the program please contact

Prof. Dr. G. Babu,

Email: devakiammapharmacycollege@gmail.com Mobile: +91 95399 39912

For sending your registrations and other enquiries please contact

M. Pharm., Ph. D., F.I.C.,

Principal, Devaki Amma Memorial College of Pharmacy,

Chelembra, Malappuram, Kerala, India

Phone: +91 483 2891623

The Administrative officer

Indian Association of Colleges of Pharmacy

"Prasanna Enclave", First Floor, No.30, Bharathi Avenue Second Street

(Near Kotturpuram Railway Station), Kotturpuram

Chennai - 600 085, Tamil Nadu, India

Tel. No: + 91 - 44 - 2442 2211 Fax No: + 91 - 44 - 2442 2211

Email: Website: www.iacp.org.incontact@iacp.org.in

Registration